Wednesday, 02 July 2025

Pfizer-BioNTech

Pfizer-jab
Pfizer jab produces less antibodies against Delta variant: Lancet
Pfizer jab produces less antibodies against Delta variant: Lancet
Pfizer-COVID Vaccine-USA-India
Pfizer's insistence on indemnity against adverse effects delaying approval of its Covid-19 vaccine in India: Report 
Pfizer's insistence on indemnity against adverse effects delaying approval of its Covid-19 vaccine in India: Report 
Canada OKs Pfizer vaccine for adolescents, pfixer, Pfizer covid 19 vaccine, Vaccine for adolscents, Covid 19 vaccine for kids
Canada OKs Pfizer vaccine for adolescents
Canada OKs Pfizer vaccine for adolescents
Pfizer, Covid vaccination, Pfizer CEO, Covid jabs for kids: Pfizer to seek approval in Sep, Covid vaccination for kids
Covid jabs for kids: Pfizer to seek approval in Sep
Covid jabs for kids: Pfizer to seek approval in Sep
United States, United States FDA, US FDA to authorise Pfizer jabs, Pfizer jabs for 12 to 15-year-old by next week
US FDA to authorise Pfizer jabs for 12 to 15-year-old by next week
US FDA to authorise Pfizer jabs for 12 to 15-year-old by next week
Pfizer, Covid vaccination, Pfizer CEO, Pfizer in talks with India, Pfizer covid vaccine
Pfizer in talks with India on vax approval, says CEO
Pfizer in talks with India on vax approval, says CEO
Pfizer-BioNTech-COVID vaccine-Phase 3
Pfizer/BioNTech vax highly effective after 6 months
Pfizer/BioNTech vax highly effective after 6 months
Pfizer-BioNTech
Pfizer withdraws application for Covid-19 vaccine in India
Pfizer withdraws application for Covid-19 vaccine in India
Advertisement